Heather Bowers
Acute Care · Greenville, SCNPI 1336376607
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (57.6%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Incyte Corporation accounts for 94.3% of it on its own, with 13 other manufacturers making up the rest. Among acute care clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 197 payments — averaging $475.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$88K
- Pfizer$5K
- Seagen Inc.$325
- Ipsen Biopharmaceuticals, Inc$46
- Astellas Pharma US Inc$41
- Sanofi$37
- plus $156 from 8 others
What the payments were for
- Consulting fees$10,12511%
- Speaking & faculty fees$53,88558%
- Travel & lodging$25,80328%
- Food & beverage$3,4964%
- Education$2800%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 166 | $88,276 |
| Pfizer | 17 | $4,708 |
| Seagen Inc. | 1 | $325 |
| Ipsen Biopharmaceuticals, Inc | 2 | $46 |
| Astellas Pharma US Inc | 2 | $41 |
| Sanofi | 1 | $37 |
| GSK | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| Novartis | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| AstraZeneca | 1 | $19 |
| Kyowa Kirin, Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Genentech USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$93,588 in reported general payments places this provider in the 95th percentile of 339 acute care providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydromorphone Hcl | 12 | $143 |
| Ondansetron Hcl | 11 | $2 |
Paid to pharmacies, not to this prescriber.
Other acute care in Greenville
- Sarah MatthewsGreenville$28K
- Susan FunkGreenville$11K
- Jeffrey CobbGreenville$8K
- Jamez FletcherGreenville$7K
- Serena KocourekGreenville$7K
- Taylor NewtonGreenville$6K
- Cheryl MartinezGreenville$6K
- Stephanie RodriguezGreenville$6K
- Lucretia MyersGreenville$5K
- Jessica SentellGreenville$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.